Evidence map›Paper›PMID 20080559›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Controlling the enzymatic activity of a restriction enzyme by light.

Benno Schierling, Ann-Josée Noël, Wolfgang Wende, Le Thi Hien, Eugeny Volkov, Elena Kubareva, Tatiana Oretskaya, Michael Kokkinidis, Andreas Römpp, Bernhard Spengler and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 176 citations in OpenAlex.

  1. Article
  2. Review
  3. Design of a light and CaProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Cystine Knot Peptides with Tuneable Activity and Mechanism.Angewandte Chemie (International ed. in English) · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Sensing the allosteric force.Nature communications · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Engineering Allostery into Proteins.Advances in experimental medicine and biology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Benno SchierlingInstitute of Biochemistry, Justus-Liebig University, Giessen, Germany.
Ann-Josée Noël
Wolfgang Wende
Le Thi Hien
Eugeny Volkov
Elena Kubareva
Tatiana Oretskaya
Michael Kokkinidis
Andreas Römpp
Bernhard Spengler
Alfred Pingoud
University of Giessen · DELomonosov Moscow State University · RUUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For many applications it would be desirable to be able to control the activity of proteins by using an external signal. In the present study, we have explored the possibility of modulating the activity of a restriction enzyme with light. By cross-linking two suitably located cysteine residues with a bifunctional azobenzene derivative, which can adopt a cis- or trans-configuration when illuminated by UV or blue light, respectively, enzymatic activity can be controlled in a reversible manner. To determine which residues when cross-linked show the largest "photoswitch effect," i.e., difference in activity when illuminated with UV vs. blue light, > 30 variants of a single-chain version of the restriction endonuclease PvuII were produced, modified with azobenzene, and tested for DNA cleavage activity. In general, introducing single cross-links in the enzyme leads to only small effects, whereas with multiple cross-links and additional mutations larger effects are observed. Some of the modified variants, which carry the cross-links close to the catalytic center, can be modulated in their DNA cleavage activity by a factor of up to 16 by illumination with UV (azobenzene in cis) and blue light (azobenzene in trans), respectively. The change in activity is achieved in seconds, is fully reversible, and, in the case analyzed, is due to a change in V(max) rather than K(m).

Indexed as

LightUltraviolet RaysAlternative SplicingAzo CompoundsBinding SitesBiocatalysisCross-Linking ReagentsCrystallography, X-RayDNA Restriction EnzymesEnzyme ActivationIsomerismModels, MolecularProtein BindingProtein Interaction Domains and MotifsProtein Structure, TertiaryazobenzeneAzo CompoundsCross-Linking ReagentsDNA Restriction Enzymes

Identifiers

PMID20080559
PMCPMC2824348
OpenAlexW2126063957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.